I can speak to this, if I may. Yes, I agree with Joel that they're complementary. In what I presented, I was really focusing on independent appraisal by people not involved at all in the clinical trial and people who weren't necessarily government regulators. At the same time, I would absolutely reinforce and agree with what Joel is suggesting.
I am on the record as saying this for about 10 years. In Canada, everywhere, it would be ideal if industry would give over the money they're spending on trials—which they partially give to academic researchers—and instead give that money to a completely independent source, like perhaps CIHR, who could then determine who could do these trials, so that the clinical researchers are not going cap in hand to industry to conduct the trials for them.